Cassava Sciences says US DOJ has closed investigation into company

Core Viewpoint - The U.S. Department of Justice has concluded its investigation into Cassava Sciences regarding allegations of research misconduct related to its Alzheimer's drug simufilam [1] Company Summary - Cassava Sciences announced the end of the DOJ probe, which focused on allegations concerning the integrity of research conducted for simufilam [1]